Effectiveness of COVID-19 mRNA Vaccines Against Hospitalizations
Author Information
Author(s): Bill K.-F. Wong, Neil A. Mabbott
Primary Institution: University of Edinburgh
Hypothesis
What is the real-world effectiveness of COVID-19 mRNA vaccines against hospitalizations in adults?
Conclusion
The Pfizer/BioNTech and Moderna mRNA vaccines provide strong protection against COVID-19 hospitalizations, but effectiveness may decrease with the Omicron variant.
Supporting Evidence
- High vaccine effectiveness was reported for both BNT162b2 and mRNA-1273 vaccines.
- Meta-analysis indicated pooled effectiveness estimates ranged from 84% to 86%.
- Booster doses can restore waning effectiveness.
- VE was lower during the prevalence of the Omicron variant.
Takeaway
The COVID-19 vaccines from Pfizer and Moderna work really well to keep people out of the hospital, but they might not work as well against some new virus types.
Methodology
A systematic review and meta-analysis of 50 studies evaluating vaccine effectiveness against COVID-19 hospitalization.
Potential Biases
Potential biases due to the exclusion of studies from underrepresented regions.
Limitations
The review had uneven geographical representation and did not account for follow-up duration variability.
Participant Demographics
Studies included adults over 18 years old, with a majority from the United States, Israel, and the United Kingdom.
Statistical Information
P-Value
<.0001
Confidence Interval
80.27–88.40
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website